벤젠 유도체의 신규 결정형
본 발명에 따른 화합물은 강력한 신경 보호 및/또는 수복 작용을 가지므로, 신경장해(예컨대, 만성 염증성 탈수성 다발 신경염, 길랭-바레 증후군, 결절성 동맥 주위염, 알레르기성 혈관염, 당뇨병성 말초신경장해, 교액성 신경장해, 화학요법약 투여에 따른 말초신경장해, 또는 샤르코 마리 투스병에 따른 말초신경장해 등)의 치료제로서 작용할 수 있다. 또한 그 화합물의 결정은 의약품 원약으로서 우수한 취급 특성을 갖는다. A compound according to the present invention has a strong neuropr...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FUJITO TAKAYUKI NISHIUMA NAOKI OHTANI SHUHEI |
| description | 본 발명에 따른 화합물은 강력한 신경 보호 및/또는 수복 작용을 가지므로, 신경장해(예컨대, 만성 염증성 탈수성 다발 신경염, 길랭-바레 증후군, 결절성 동맥 주위염, 알레르기성 혈관염, 당뇨병성 말초신경장해, 교액성 신경장해, 화학요법약 투여에 따른 말초신경장해, 또는 샤르코 마리 투스병에 따른 말초신경장해 등)의 치료제로서 작용할 수 있다. 또한 그 화합물의 결정은 의약품 원약으로서 우수한 취급 특성을 갖는다.
A compound according to the present invention has a strong neuroprotective action and/or a neurorepair action, and therefore can serve as a therapeutic agent for neurological disorders (e.g., chronic inflammatory demyelinating polyneuritis, Guillain-Barre syndrome, periarteritis nodosa, allergic angiitis, diabetic peripheral neuropathy, entrapment syndrome, peripheral neuropathy associated with administration of chemotherapy medication, and peripheral neuropathy associated with Charcot-Marie-Tooth disease). Moreover, the crystals of the compound have excellent handling properties as a bulk drug substance. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20220132537A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20220132537A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20220132537A3</originalsourceid><addsrcrecordid>eNrjZFB5vWnJmwULFN7MWfC6v-XNpi1v5s5QeNO94NX2OQqvNm14s2Dq2xlTeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvHeQkYGRkYGhsZGpsbmjMXGqADacMh4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>벤젠 유도체의 신규 결정형</title><source>esp@cenet</source><creator>FUJITO TAKAYUKI ; NISHIUMA NAOKI ; OHTANI SHUHEI</creator><creatorcontrib>FUJITO TAKAYUKI ; NISHIUMA NAOKI ; OHTANI SHUHEI</creatorcontrib><description>본 발명에 따른 화합물은 강력한 신경 보호 및/또는 수복 작용을 가지므로, 신경장해(예컨대, 만성 염증성 탈수성 다발 신경염, 길랭-바레 증후군, 결절성 동맥 주위염, 알레르기성 혈관염, 당뇨병성 말초신경장해, 교액성 신경장해, 화학요법약 투여에 따른 말초신경장해, 또는 샤르코 마리 투스병에 따른 말초신경장해 등)의 치료제로서 작용할 수 있다. 또한 그 화합물의 결정은 의약품 원약으로서 우수한 취급 특성을 갖는다.
A compound according to the present invention has a strong neuroprotective action and/or a neurorepair action, and therefore can serve as a therapeutic agent for neurological disorders (e.g., chronic inflammatory demyelinating polyneuritis, Guillain-Barre syndrome, periarteritis nodosa, allergic angiitis, diabetic peripheral neuropathy, entrapment syndrome, peripheral neuropathy associated with administration of chemotherapy medication, and peripheral neuropathy associated with Charcot-Marie-Tooth disease). Moreover, the crystals of the compound have excellent handling properties as a bulk drug substance.</description><language>kor</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220930&DB=EPODOC&CC=KR&NR=20220132537A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220930&DB=EPODOC&CC=KR&NR=20220132537A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FUJITO TAKAYUKI</creatorcontrib><creatorcontrib>NISHIUMA NAOKI</creatorcontrib><creatorcontrib>OHTANI SHUHEI</creatorcontrib><title>벤젠 유도체의 신규 결정형</title><description>본 발명에 따른 화합물은 강력한 신경 보호 및/또는 수복 작용을 가지므로, 신경장해(예컨대, 만성 염증성 탈수성 다발 신경염, 길랭-바레 증후군, 결절성 동맥 주위염, 알레르기성 혈관염, 당뇨병성 말초신경장해, 교액성 신경장해, 화학요법약 투여에 따른 말초신경장해, 또는 샤르코 마리 투스병에 따른 말초신경장해 등)의 치료제로서 작용할 수 있다. 또한 그 화합물의 결정은 의약품 원약으로서 우수한 취급 특성을 갖는다.
A compound according to the present invention has a strong neuroprotective action and/or a neurorepair action, and therefore can serve as a therapeutic agent for neurological disorders (e.g., chronic inflammatory demyelinating polyneuritis, Guillain-Barre syndrome, periarteritis nodosa, allergic angiitis, diabetic peripheral neuropathy, entrapment syndrome, peripheral neuropathy associated with administration of chemotherapy medication, and peripheral neuropathy associated with Charcot-Marie-Tooth disease). Moreover, the crystals of the compound have excellent handling properties as a bulk drug substance.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB5vWnJmwULFN7MWfC6v-XNpi1v5s5QeNO94NX2OQqvNm14s2Dq2xlTeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvHeQkYGRkYGhsZGpsbmjMXGqADacMh4</recordid><startdate>20220930</startdate><enddate>20220930</enddate><creator>FUJITO TAKAYUKI</creator><creator>NISHIUMA NAOKI</creator><creator>OHTANI SHUHEI</creator><scope>EVB</scope></search><sort><creationdate>20220930</creationdate><title>벤젠 유도체의 신규 결정형</title><author>FUJITO TAKAYUKI ; NISHIUMA NAOKI ; OHTANI SHUHEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20220132537A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2022</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FUJITO TAKAYUKI</creatorcontrib><creatorcontrib>NISHIUMA NAOKI</creatorcontrib><creatorcontrib>OHTANI SHUHEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FUJITO TAKAYUKI</au><au>NISHIUMA NAOKI</au><au>OHTANI SHUHEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>벤젠 유도체의 신규 결정형</title><date>2022-09-30</date><risdate>2022</risdate><abstract>본 발명에 따른 화합물은 강력한 신경 보호 및/또는 수복 작용을 가지므로, 신경장해(예컨대, 만성 염증성 탈수성 다발 신경염, 길랭-바레 증후군, 결절성 동맥 주위염, 알레르기성 혈관염, 당뇨병성 말초신경장해, 교액성 신경장해, 화학요법약 투여에 따른 말초신경장해, 또는 샤르코 마리 투스병에 따른 말초신경장해 등)의 치료제로서 작용할 수 있다. 또한 그 화합물의 결정은 의약품 원약으로서 우수한 취급 특성을 갖는다.
A compound according to the present invention has a strong neuroprotective action and/or a neurorepair action, and therefore can serve as a therapeutic agent for neurological disorders (e.g., chronic inflammatory demyelinating polyneuritis, Guillain-Barre syndrome, periarteritis nodosa, allergic angiitis, diabetic peripheral neuropathy, entrapment syndrome, peripheral neuropathy associated with administration of chemotherapy medication, and peripheral neuropathy associated with Charcot-Marie-Tooth disease). Moreover, the crystals of the compound have excellent handling properties as a bulk drug substance.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20220132537A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 벤젠 유도체의 신규 결정형 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T16%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FUJITO%20TAKAYUKI&rft.date=2022-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20220132537A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |